Mehta Rohtesh S, Liman Andrew D, Passero Vida A, Liman Agnes K
University of Pittsburgh Medical Center, Pittsburgh, USA,
Cancer Microenviron. 2013 Dec;6(3):203-11. doi: 10.1007/s12307-013-0135-1. Epub 2013 Aug 21.
Approximately 1 in 14 men and women during their lifetime will be diagnosed with lung cancer, which is the leading cause of cancer-related mortality in the world. As of January 1, 2008, there were about 373,500 men and women living with lung cancer in the United States. Fewer than 60,000 of these are estimated to be alive by January 2013, reflecting a poor overall 5-year relative survival rate of under 16 %. With metastatic cancer, the overall 5-year survival is meager 4 %. On the other hand, the overall five-year survival is over 50 % when the cancer is still in the localized stage. However, unfortunately, more than half of cases of lung cancer are diagnosed at an advanced stage Howlader et al. (2010). Cancer metastasis, the single most critical prognostic factor, is still poorly understood and a highly complex phenomenon. The most common sites of lung cancer metastasis are the lymph nodes, liver, adrenals, brain and bones. The gastrointestinal (GI) tract is an exceptionally rare site of metastasis; with only a handful of cases reported in the literature Centeno et al. (Lung Cancer, 18: 101-105, 1997); Hirasaki et al. (World J Gastroenterol, 14: 5481-5483, 2008); Carr and Boulos (Br J Surg, 83: 647, 1996); Otera et al. (Eur Respir Rev, 19: 248-252, 2010); Antler et al. (Cancer, 49: 170-172, 1982); Fujiwara et al. (Gen Thorac Cardiovasc Surg, 59: 748-752, 2011); Stinchcombe et al. (J Clin Oncol, 24: 4939-4940, 2006); John et al. (J Postgrad Med, 48: 199-200, 2002); Carroll and Rajesh (Eur J Cardiothorac Surg, 19: 719-720, 2001); Brown et al. (Dis Colon Rectum, 23: 343-345, 1980). We report three cases of non-small cell (squamous cell) lung cancer with GI tract metastasis-two in the colon and one in the jejunum. Then we present a review of literature exploring various theories of metastasis, as an attempt to understand the reason of preferential tumor metastasis.
在一生中,大约每14名男性和女性中就有1人会被诊断出患有肺癌,肺癌是全球癌症相关死亡的主要原因。截至2008年1月1日,美国约有373,500名男性和女性患有肺癌。据估计,到2013年1月,这些人中存活的不到60,000人,这反映出总体5年相对生存率很低,不到16%。对于转移性癌症,总体5年生存率仅为4%。另一方面,当癌症仍处于局部阶段时,总体5年生存率超过50%。然而,不幸的是,超过一半的肺癌病例在晚期才被诊断出来(豪拉德等人,2010年)。癌症转移是最关键的预后因素,但人们对其仍知之甚少,它是一个高度复杂的现象。肺癌转移最常见的部位是淋巴结、肝脏、肾上腺、大脑和骨骼。胃肠道是极其罕见的转移部位;文献中仅报道了少数病例(森特诺等人,《肺癌》,第18卷:第101 - 105页,1997年;平崎等人,《世界胃肠病学杂志》,第14卷:第5481 - 5483页,2008年;卡尔和布罗斯,《英国外科杂志》,第83卷:第647页,1996年;奥特拉等人,《欧洲呼吸病学评论》,第19卷:第248 - 252页,2010年;安特勒等人,《癌症》,第49卷:第170 - 172页,1982年;藤原等人,《胸心血管外科杂志》,第59卷:第748 - 752页,2011年;斯廷科姆等人,《临床肿瘤学杂志》,第24卷:第4939 - 4940页,2006年;约翰等人,《研究生医学杂志》,第48卷:第199 - 200页,2002年;卡罗尔和拉杰什,《欧洲心胸外科杂志》,第19卷:第719 - 720页,2001年;布朗等人,《结肠直肠疾病》,第23卷:第343 - 345页,1980年)。我们报告了3例非小细胞(鳞状细胞)肺癌发生胃肠道转移的病例——2例发生在结肠,1例发生在空肠。然后我们对文献进行综述,探讨各种转移理论,试图理解肿瘤优先转移的原因。